Development of nonnucleoside HIV reverse transcriptase inhibitors

Methods Enzymol. 1996:275:440-72. doi: 10.1016/s0076-6879(96)75026-7.
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-HIV Agents / chemical synthesis*
  • Anti-HIV Agents / chemistry
  • Anti-HIV Agents / pharmacology
  • Cell Line
  • Cell Survival / drug effects
  • Drug Design
  • HIV Infections / drug therapy
  • HIV Reverse Transcriptase / antagonists & inhibitors*
  • HIV Reverse Transcriptase / chemistry*
  • HIV-1 / drug effects
  • HIV-1 / enzymology
  • Humans
  • Models, Molecular
  • Molecular Conformation
  • Molecular Structure
  • Nevirapine
  • Protein Conformation
  • Pyridines / chemistry
  • Pyridines / pharmacology
  • Reverse Transcriptase Inhibitors / chemical synthesis*
  • Reverse Transcriptase Inhibitors / chemistry
  • Reverse Transcriptase Inhibitors / pharmacology
  • Structure-Activity Relationship

Substances

  • Anti-HIV Agents
  • Pyridines
  • Reverse Transcriptase Inhibitors
  • Nevirapine
  • HIV Reverse Transcriptase